These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

295 related articles for article (PubMed ID: 36755294)

  • 21. Contralateral axillary sentinel lymph node in breast cancer recurrence.
    Cairns C; Greenwalt I; Fan KL; Willey SC
    Breast J; 2020 Jul; 26(7):1379-1381. PubMed ID: 32291826
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Sentinel Node and Recurrent Breast Cancer (SNARB): results of a nationwide registration study.
    Maaskant-Braat AJ; Roumen RM; Voogd AC; Pijpers R; Luiten EJ; Rutgers EJ; Nieuwenhuijzen GA
    Ann Surg Oncol; 2013 Feb; 20(2):620-6. PubMed ID: 22941173
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Meta-analysis of aberrant lymphatic drainage in recurrent breast cancer.
    Ahmed M; Baker R; Rubio IT
    Br J Surg; 2016 Nov; 103(12):1579-1588. PubMed ID: 27598038
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Second axillary sentinel node biopsy for ipsilateral breast tumour recurrence.
    Intra M; Trifirò G; Galimberti V; Gentilini O; Rotmensz N; Veronesi P
    Br J Surg; 2007 Oct; 94(10):1216-9. PubMed ID: 17583891
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Sentinel lymph node mapping in breast cancer: a critical reappraisal of the internal mammary chain issue.
    Manca G; Volterrani D; Mazzarri S; Duce V; Svirydenka A; Giuliano A; Mariani G
    Q J Nucl Med Mol Imaging; 2014 Jun; 58(2):114-26. PubMed ID: 24835288
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Second biopsy of axillary sentinel lymph node for reappearing breast cancer after previous sentinel lymph node biopsy.
    Intra M; Trifirò G; Viale G; Rotmensz N; Gentilini OD; Soteldo J; Galimberti V; Veronesi P; Luini A; Paganelli G; Veronesi U
    Ann Surg Oncol; 2005 Nov; 12(11):895-9. PubMed ID: 16195833
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Discordance between number of scintigraphic and perioperatively identified sentinel lymph nodes and axillary tumour recurrence.
    Volders JH; van la Parra RF; Bavelaar-Croon CD; Barneveld PC; Ernst MF; Bosscha K; De Roos WK
    Breast; 2014 Apr; 23(2):159-64. PubMed ID: 24456968
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A comparative study on the value of FDG-PET and sentinel node biopsy to identify occult axillary metastases.
    Veronesi U; De Cicco C; Galimberti VE; Fernandez JR; Rotmensz N; Viale G; Spano G; Luini A; Intra M; Veronesi P; Berrettini A; Paganelli G
    Ann Oncol; 2007 Mar; 18(3):473-8. PubMed ID: 17164229
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Evaluation of the Usefulness of FDG-PET/CT for Nodal Staging of Breast Cancer.
    Orsaria P; Chiaravalloti A; Caredda E; Marchese PV; Titka B; Anemona L; Portarena I; Schillaci O; Petrella G; Palombi L; Buonomo OC
    Anticancer Res; 2018 Dec; 38(12):6639-6652. PubMed ID: 30504372
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Breast cancer patients with extra-axillary sentinel nodes only may be spared axillary lymph node dissection.
    van der Ploeg IM; Tanis PJ; Valdés Olmos RA; Kroon BB; Rutgers EJ; Nieweg OE
    Ann Surg Oncol; 2008 Nov; 15(11):3239-43. PubMed ID: 18773244
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Staging and management of axillary lymph nodes in patients with local recurrence in the breast or chest wall after a previous negative sentinel node procedure.
    Derkx F; Maaskant-Braat AJ; van der Sangen MJ; Nieuwenhuijzen GA; van de Poll-Franse LV; Roumen RM; Voogd AC
    Eur J Surg Oncol; 2010 Jul; 36(7):646-51. PubMed ID: 20537838
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Lymphoscintigraphy in breast cancer patients after neoadjuvant chemotherapy. Diagnostic value and the work-up of sentinel node negative patients.
    Dalus K; Reitsamer R; Holzmannhofer J; Rendl G; Pirich C; Kronberger C; Rettenbacher L
    Nuklearmedizin; 2011; 50(1):33-8. PubMed ID: 21336417
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Failed preoperative lymphoscintigraphy for sentinel lymph node biopsy in breast cancer, possible causes and implications for the surgery - the analysis of 3014 procedures].
    Coufal O; Zapletal O; Vrtělová P; Vašina J; Řehák Z
    Rozhl Chir; 2015 Mar; 94(3):126-30. PubMed ID: 25754481
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Second Axillary Sentinel Lymph Node Biopsy for Breast Tumor Recurrence: Experience of the European Institute of Oncology.
    Intra M; Viale G; Vila J; Grana CM; Toesca A; Gentilini O; Galimberti V; Veronesi P; Luini A; Rotmensz N; Bagnardi V; Mattar D; Colleoni M
    Ann Surg Oncol; 2015 Jul; 22(7):2372-7. PubMed ID: 25515197
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Narrative review of sentinel lymph node biopsy in breast cancer: a technique in constant evolution with still numerous unresolved questions.
    Mathelin C; Lodi M
    Chin Clin Oncol; 2021 Apr; 10(2):20. PubMed ID: 33353365
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [A Case of Ipsilateral Breast Cancer with Contralateral Axillary Node Recurrence after Right Breast Partial Mastectomy].
    Adachi M; Hara M; Ishibashi N; Sasaki M; Tomii C; Ohshima N; Koshiishi H; Yoshimura T
    Gan To Kagaku Ryoho; 2020 Dec; 47(13):2198-2200. PubMed ID: 33468906
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Experience of sentinel node biopsy alone in early breast cancer without further axillary dissection in patients with negative sentinel node.
    Soni NK; Spillane AJ
    ANZ J Surg; 2005 May; 75(5):292-9. PubMed ID: 15932439
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Management of the axilla in patients with breast cancer and positive sentinel lymph node biopsy: An evidence-based update in a European breast center.
    Garcia-Etienne CA; Ferrari A; Della Valle A; Lucioni M; Ferraris E; Di Giulio G; Squillace L; Bonzano E; Lasagna A; Rizzo G; Tancredi R; Scotti Foglieni A; Dionigi F; Grasso M; Arbustini E; Cavenaghi G; Pedrazzoli P; Filippi AR; Dionigi P; Sgarella A
    Eur J Surg Oncol; 2020 Jan; 46(1):15-23. PubMed ID: 31445768
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Contribution of SPECT/CT for sentinel node localization in patients with ipsilateral breast cancer relapse.
    Borrelli P; Donswijk ML; Stokkel MP; Teixeira SC; van Tinteren H; Rutgers EJ; Valdés Olmos RA
    Eur J Nucl Med Mol Imaging; 2017 Apr; 44(4):630-637. PubMed ID: 27787592
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Incidence of axillary recurrence in 344 sentinel node negative breast cancer patients after intermediate follow-up. A prospective study into the accuracy of sentinel node biopsy in breast cancer patients.
    Heuts EM; van der Ent FW; Hulsewé KW; Heeren PA; Hoofwijk AG
    Acta Chir Belg; 2007 Jun; 107(3):279-83. PubMed ID: 17685253
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.